Search Results for compound
Searching compound for 3-methyldec-4-en-1-ol returned 66053 results.
Displaying compounds 20176 - 20200 of 66053 in total
FDB027508
4661-65-8
(2S,3S,4S,5R)-3,4,5-trihydroxy-6-{[(1S,10R,11S,13R,14R,15S)-14-hydroxy-15-methyl-5-(sulfooxy)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-2(7),3,5-trien-13-yl]oxy}oxane-2-carboxylic acid
Matched synonyms: … Estriol 3-sulfate 16-glucuronide ... Estriol 3-sulfate 16-glucuronoside ... Estriol 3-sulphate 16-glucuronide …
Matched name: … Estriol 3-sulfate 16-glucuronide …
Matched description: … Estriol 3-sulfate 16-glucuronide is a natural human metabolite of Estriol 3-sulfate generated in the …
Matched name: … Estriol 3-sulfate 16-glucuronide …
Matched description: … Estriol 3-sulfate 16-glucuronide is a natural human metabolite of Estriol 3-sulfate generated in the …
FDB028795
19355-90-9
(5S)-5-amino-3-oxohexanoic acid
Matched synonyms: … (S)-5-amino-3-oxo-Hexanoate ... 5-Amino-3-oxohexanoate ... 3-Keto-5-aminohexanoate …
Matched name: … (S)-5-Amino-3-oxohexanoate …
Matched iupac: … (5S)-5-amino-3-oxohexanoic acid …
Matched description: … S)-5-Amino-3-oxohexanoate is an intermediate in lysine degradation. ... In lysine degradation pathway, (S)-5-Amino-3-oxohexanoate is a substrate for the enzyme L-erythro-3,5 …
Matched name: … (S)-5-Amino-3-oxohexanoate …
Matched iupac: … (5S)-5-amino-3-oxohexanoic acid …
Matched description: … S)-5-Amino-3-oxohexanoate is an intermediate in lysine degradation. ... In lysine degradation pathway, (S)-5-Amino-3-oxohexanoate is a substrate for the enzyme L-erythro-3,5 …
FDB029324
120-72-9
(3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1H-indole-3-carbonyloxy)oxane-2-carboxylic acid
Matched synonyms: … 3-Indoleformate glucuronide ... 1H-Indole-3-carboxylate glucuronide ... 3-Indolecarboxylate glucuronide …
Matched name: … 3-Indole carboxylic acid glucuronide …
Matched iupac: … (3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1H-indole-3-carbonyloxy)oxane-2-carboxylic acid …
Matched description: … 3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. ... Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been …
Matched name: … 3-Indole carboxylic acid glucuronide …
Matched iupac: … (3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1H-indole-3-carbonyloxy)oxane-2-carboxylic acid …
Matched description: … 3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. ... Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been …
FDB029653
359794-78-8
(5E)-octa-1,5-dien-3-one
Matched name: … (E)-1,5-octadien-3-one …
Matched iupac: … (5E)-octa-1,5-dien-3-one …
Matched iupac: … (5E)-octa-1,5-dien-3-one …
7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
Matched synonyms: … Peonidin 3-O-diglucoside 5-O-glucoside …
Matched name: … Peonidin 3-diglucoside 5-glucoside …
Matched iupac: … 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2 ... )oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium ... -yl]oxy}-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl …
Matched name: … Peonidin 3-diglucoside 5-glucoside …
Matched iupac: … 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2 ... )oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium ... -yl]oxy}-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl …
5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one
Matched name: … kaempferol 3-rhamnoside-7-glucoside …
Matched iupac: … 5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S ... ,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one …
Matched iupac: … 5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-{[(2S ... ,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4H-chromen-4-one …
FDB006899
483-77-2
(1S,4S)-1,6-dimethyl-4-(propan-2-yl)-1,2,3,4-tetrahydronaphthalene
Matched name: … 1-S-cis-Calamenene …
Matched iupac: … (1S,4S)-1,6-dimethyl-4-(propan-2-yl)-1,2,3,4-tetrahydronaphthalene …
Matched iupac: … (1S,4S)-1,6-dimethyl-4-(propan-2-yl)-1,2,3,4-tetrahydronaphthalene …
FDB011528
30634-66-3
4-(methoxymethyl)-7-methyl-5H,6H,7H-cyclopenta[c]pyridine
Matched iupac: … 4-(methoxymethyl)-7-methyl-5H,6H,7H-cyclopenta[c]pyridine …
FDB012309
10338-88-2
[3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl acetate
Matched iupac: … [3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl acetate …
FDB017443
15890-31-0
(4S,4aR,8aS)-1,6-dimethylidene-4-(propan-2-yl)-decahydronaphthalene
Matched iupac: … (4S,4aR,8aS)-1,6-dimethylidene-4-(propan-2-yl)-decahydronaphthalene …
FDB018754
2650-74-0
(2S)-2-amino-4-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]butanoic acid
Matched iupac: … (2S)-2-amino-4-[(2-hydroxyethyl)-C-hydroxycarbonimidoyl]butanoic acid …
FDB018925
90275-97-1
[3,4,5-trihydroxy-4-(hydroxymethyl)oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate
Matched iupac: … [3,4,5-trihydroxy-4-(hydroxymethyl)oxolan-2-yl]methyl 3,4,5-trihydroxybenzoate …
FDB021375
146064-66-6
6-(hydroxymethyl)-2-methyl-3,4-dihydro-2H-pyran-4-one
Matched synonyms: … (2S)-2,3-Dihydro-6-hydroxymethyl-2-methyl-4H-pyran-4-one …
Matched iupac: … 6-(hydroxymethyl)-2-methyl-3,4-dihydro-2H-pyran-4-one …
Matched iupac: … 6-(hydroxymethyl)-2-methyl-3,4-dihydro-2H-pyran-4-one …
FDB022849
75762-47-9
2-amino-6-[(2S)-2,3-dihydroxypropanoyl]-1,4,7,8-tetrahydropteridin-4-one
Matched synonyms: … 3'-Hydroxysepiapterin …
Matched iupac: … 2-amino-6-[(2S)-2,3-dihydroxypropanoyl]-1,4,7,8-tetrahydropteridin-4-one …
Matched description: … 3'-hydroxysepiapterin is found in high concentration in the urine of patients with DHBS(dihydrobiopterin …
Matched iupac: … 2-amino-6-[(2S)-2,3-dihydroxypropanoyl]-1,4,7,8-tetrahydropteridin-4-one …
Matched description: … 3'-hydroxysepiapterin is found in high concentration in the urine of patients with DHBS(dihydrobiopterin …
(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanoic acid
Matched iupac: … (2S)-2-[(2S)-2-amino-4-carboxybutanamido]-5-carbamimidamidopentanoic acid …
6-amino-2-[(4-hydroxypyrrolidin-2-yl)formamido]hexanoic acid
Matched iupac: … 6-amino-2-[(4-hydroxypyrrolidin-2-yl)formamido]hexanoic acid …
[2-hydroxy-3-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadeca-9,12-dienoyloxy)propoxy]phosphoryl}oxy)propoxy][(2R)-3-(icos-11-enoyloxy)-2-(octadeca-9,12-dienoyloxy)propoxy]phosphinic acid
Matched synonyms: … 1'-[1-Eicosenoyl-2-linoleoyl-sn-glycero-3-O],3'-[1,2-dilinoleoyl-rac-glycero-3-O]-glycerol ... CL(1'-[20:1(11Z)/18:2(9Z,12Z)],3'-[18:2(9Z,12Z)/18:2(9Z,12Z)]) ... CL(20:1/18:2/18:2/18:2) …
Matched name: … CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)) …
Matched iupac: … [2-hydroxy-3-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadeca-9,12-dienoyloxy)propoxy]phosphoryl}oxy ... )propoxy][(2R)-3-(icos-11-enoyloxy)-2-(octadeca-9,12-dienoyloxy)propoxy]phosphinic acid …
Matched description: … CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)) is a cardiolipin (CL). …
Matched name: … CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)) …
Matched iupac: … [2-hydroxy-3-({hydroxy[(2R)-2-(octadec-11-enoyloxy)-3-(octadeca-9,12-dienoyloxy)propoxy]phosphoryl}oxy ... )propoxy][(2R)-3-(icos-11-enoyloxy)-2-(octadeca-9,12-dienoyloxy)propoxy]phosphinic acid …
Matched description: … CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)) is a cardiolipin (CL). …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-tetradecanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched iupac: … )oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl ... -6-{[(2S,3R)-3-hydroxy-2-tetradecanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl ... )oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid ... (2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5- ... acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched iupac: … hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy- ... -2-hexadecanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-( ... 6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic ... (2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5- ... acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R) …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-docosanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched iupac: … )oxan-3-yl]oxy}-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl ... -2-docosanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-5-hydroxy-2-(hydroxymethyl ... )oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid ... (2S,4S,5R)-2-{[(2R,3R,4S,5S,6R)-2-{[(2S,3R,4R,5R,6R)-2-{[(2R,3S,4R,5R,6S)-4-{[(2S,4S,5R)-2-carboxy-5- ... acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-6-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R) …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-1,3-dihydroxypropyl]-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-tricosanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxyoxane-2-carboxylic acid
Matched iupac: … 5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)-4-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan ... hydroxy-2-tricosanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3-hydroxy-5-{[(2S,3R,4R,5R,6R)- ... -2-yl]oxy}oxan-2-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxyoxane-2-carboxylic acid ... (2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl ... -2-yl]oxy}-1,3-dihydroxypropyl]-2-{[(2S,3R,4R,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3- …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-1,3-dihydroxypropyl]-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-hexadecanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxyoxane-2-carboxylic acid
Matched iupac: … -4-yl]oxy}-4-hydroxyoxane-2-carboxylic acid ... dihydroxypropyl]-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-hexadecanamido-3- ... hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan ... (2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-1,3-dihydroxypropyl]-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-docosanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxyoxane-2-carboxylic acid
Matched iupac: … -4-yl]oxy}-5-acetamido-4-hydroxyoxane-2-carboxylic acid ... 2-yl]oxy}-1,3-dihydroxypropyl]-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-docosanamido-3- ... hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan ... (2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy}-1,3-dihydroxypropyl]-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-hexacosanamido-3-hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxyoxane-2-carboxylic acid
Matched iupac: … -4-yl]oxy}-4-hydroxyoxane-2-carboxylic acid ... dihydroxypropyl]-5-acetamido-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-6-{[(2S,3R)-2-hexacosanamido-3- ... hydroxyoctadecyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan ... (2S,4S,5R)-6-[(1S,2R)-2-{[(2S,4S,5R)-2-carboxy-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
(2S,4S,5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-pentacosanamidooctadecyl]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Matched iupac: … ]oxy}-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy ... (2S,4S,5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-{[(2S,3R)-3-hydroxy-2-pentacosanamidooctadecyl …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …
Matched description: … In particular, 1 stands for GalGalNAcGalGlc-ceramide, 2 stands for GalNAcGalGlc-ceramide and 3 stands ... The numbered subscripts 1, 2 and 3 refer to the carbohydrate sequence that is attached to the ceramide ... and semisynthetic gangliosides are considered possible therapeutics for neurodegenerative disorders.[1] …